Hypoglycaemia in the elderly: Presentation, counterregulation, cognitive function and prevention

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 6, 2002, Pages 451-456

  Amiel, Stephanie A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Counterregulation; Elderly; Hypoglycaemia

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; GLUCOSE; INSULIN; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; SULFONAMIDE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; TRIMETHOPRIM; WARFARIN;

ACUTE HEART INFARCTION; AGED; ALZHEIMER DISEASE; CASE REPORT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DIABETIC COMA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ALCOHOL INTERACTION; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOGLYCEMIA; HYPOPITUITARISM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

AGED; AGING; COGNITION; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HOMEOSTASIS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0036966163     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R.: Incidence and risk factors for serious hypoglycaemia in older persons using insulin or sulfonylureas. Arch. Intern. Med. 157: 1681-1686, 1997.
2. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R.: Individual sulfonylureas and serious hypoglycaemia in older people. J. Am. Geriatr. Soc. 44: 751-755, 1996.
3. UK Prospective Diabetes Study Group (UKPDS 33): Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853, 1998.
4. Chan T.Y., Lee K.K., Chan A.W., Critchley J.A.: Utilization of antidiabetic drugs in Hong Kong: relation to the common occurrence of antidiabetic drug induced hypoglycaemia amongst acute medical admissions and the relative prevalence of NIDDM. Int. J. Clin. Pharmacol. Ther. 34: 43-46, 1996.
5. Stahl M., Berger W.: Higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long acting versus short acting sulphonylureas. Diabet. Med. 16: 586-590, 1999.
6. Peacey S.R., Rostami-Hodjegan A., George E., Tucker G.T., Heller S.R.: The use of tolbutamide-induced hypoglycaemia to examine the intraislet role of insulin in mediating glucagon release in normal humans. J. Clin. Endocrinol. Metab. 82: 1458-1461, 1997.
7. Landstedt-Hallin L., Adamson U., Lins P.E.: Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycaemia in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 84: 3140-3145, 1999.
8. Tessier D., Dawson K., Tetrault J.P., Bravo G., Meneilly G.S.: Gibenclamide vs gliclazide in Type 2 diabetes of the elderly. Diabet. Med. 11: 974-980, 1994.
9. Korzon-Burakowska A., Hopkins D., Matyka K., Lomas J., Pernet A., Macdonald I.A., Amiel S.A.: Effects of glycemic control on protective responses against hypoglycaemia in type 2 diabetes mellitus. Diabetes Care 21: 282-291, 1998.
10. Jaap A.J., Jones G.C., McCrimmon R.J., Deary I.J., Frier B.M.: Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet. Med. 15: 398-401, 1998.
11. Spyer G., Hattersely A.T., Macdonald I.A., Amiel S.A., MacLeod K.M.: Hypoglycaemic conunterregulation at "normal" blood glucose concentrations in patients with well-controlled Type 2 diabetes. Lancet 356: 1970-1974, 2000.
12. Korzon-Burakowska A., Hopkins D., Matyka K., Lomas J., Pernet A., Macdonald I.A., Amiel S.A.: Effects of glycemic control on protective responses against hypoglycaemia in type 2 diabetes mellitus. Diabetes Care 21: 282-291, 1998.
13. McAuley, Frier B.M. In: Sinclair And Finucane, Diabetes in old age. (Eds.), 2001.
14. Dimitriadis G., Baker B., Marsh H., Mandarino L., Rizza R., Bergman R., Haymond M., Gerich J.: Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans Am. J. Physiol. 248: E593-E601, 1985.
15. Kerr D., MacDonald I.A., Heller S.R., Tattersall R.B.: Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. Br. J. Clin. Pharmacol. 29: 685-693, 1990.
16. Herings R.M., de Boer A., Stricker B.H., Leufkens H.G., Porsius A.: Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme Lancet 345: 1195-1198, 1995.
17. Thamer M., Ray N.F., Taylor T.: Association between antihypertensive drug use and hypoglycaemia: a case-control study of diabetic users of insulin or sulfonylureas. Clin. Ther. 21: 1387-1400, 1999.
18. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R.: Antihypertensives and the risk of serious hypoglycaemia in older persons using insulin or sulfonylureas. J.A.M.A. 278: 40-43, 1997.